Status | Study |
Active, not recruiting |
Study Name: FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma Condition: Astrocytoma Oligoastrocytoma Date: 2010-03-17 |
Terminated |
Study Name: Treatment Strategy for Low-grade Gliomas Condition: Astrocytomas Oligodendrogliomas Olig Date: 2009-05-08 Interventions: Radiation: Radiation therapy Drug: Temozol |
Completed |
Study Name: HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas Condition: Astrocytoma Oligoastrocytoma Date: 2009-04-02 Interventions: Biological: Peptide vaccine + Poly-ICLC Subcutaneously in |
Completed |
Study Name: Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma Condition: Low-grade Glioma Astrocytoma Oligodendroglioma Date: 2009-01-13 Interventions: Drug: RAD001 RAD001 will be administered orally as once daily dose of 10 mg (two 5 mg tablets) continuou |
Completed |
Study Name: Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas Condition: Astrocytoma Oligo-Astrocytoma Date: 2008-11-19 Interventions: Biological: GAA/TT-peptide vaccine and poly-ICLC Participants will be treated with subcutaneous injectio |
Completed |
Study Name: Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide Condition: Anaplastic Astrocytoma Oligodendroglioma Date: 2008-07-15 Interventions: Drug: Temozolomide 200 mg/m2 b |
Active, not recruiting |
Study Name: Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Condition: Central Nervous System Tumors Brain Tumor Date: 2006-11-16 Interventions: Drug: temozolomide Schedule of Temozolomide administration: Temozolomide, 150 mg/m2/d x days 1-7 and 15- |
Terminated |
Study Name: A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma Condition: Glioma Astrocytoma Oligodendroglioma Date: 2006-10-16 Interventions: Drug: Temozolomide and O6-Benzylguanine O6BG + Temozolomide |
Completed |
Study Name: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma Condition: Oligoastrocytoma, Mixed Anaplastic Oligodendroglioma Date: 2006-08-08 Interventions: Drug: Temozolomide p.o.(by mouth), 150 mg/m2/d x days 1-7 |
Recruiting |
Study Name: Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors Condition: Adult Anaplastic Oligodendroglioma Adult Mixed Glioma Adul Date: 2006-03-15 Interventions: Drug: Carboplatin Given IA |